April 28, 2021 — Hoya Vision Care has shared the results of a three-year follow-up clinical study on its MiYOSMART spectacle lens with patented Defocus Incorporated Multiple Segments Technology after releasing the information at the European Academy of Optometry and Optics 2021 conference, which took place April 23-25. 

The latest study was published in the British Journal of Ophthalmology in March 2021 and was conducted by the Centre for Myopia Research at The Hong Kong Polytechnic University. It serves as a follow up to the two-year study (published in May 2019), which previously demonstrated evidence of the effectiveness of the lens in slowing down the progression of myopia in children ages 8-13, shares the company. 

The three-year follow-up study, conducted on 120 children in Asia, included 65 from the original group using MiYOSMART lens who took part in the previous study and 55 children who moved from using a single-vision lens for two years to the MiYOSMART lens in the third year. Hoya has shared that at the conclusion of the third year, results in the original group of children using MiYOSMART lens showed that slowing in myopia progression over time was sustained and the group that moved from regular single-vision to MiYOSMART spectacle lens showed a significant and immediate slow-down in the progression of myopia. 

The MiYOSMART spectacle lens was developed in cooperation with The Hong Kong Polytechnic University to address myopia, and was launched in some markets in mid-2018. The lens has not been approved for myopia management in all countries, including the U.S., and is not currently available for sale in all countries, including the U.S. 

Hoya Vision care shares that the lens uses patented technology that provides children with sharp vision, can be placed in any children’s frame, and appears as a regular lens. Furthermore, based on the three-year follow-up study, the MiYOSMART lens can slow and in some cases halt myopia progression by utilizing myopic defocus, shares Hoya.

“The results of the three-year study on the MiYOSMART lens are very positive with the lens continuing to address the growing problem of myopia in children,” says Griff Altmann, chief technology officer at Hoya Vision Care. “Hoya Vision Care is proud to be a leader in developing a safe, effective way to manage the growing problem and we will work diligently to continue to roll out MiYOSMART globally.” 

The lens has received various awards, including the grand prize at the 46th International Exhibition of Inventions of Geneva in April 2018 and the Silmo d’Or in the vision category at the Silmo Paris optical show in October 2020. 

For more from Hoya: hoyavision.com/en-us/.